| Serial Number | 97225171 |
| Word Mark | MRDTECT |
| Filing Date | Tuesday, January 18, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Monday, January 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 13, 2023 |
| Goods and Services | Downloadable software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for analyzing biological samples; downloadable software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable software for health and wellness assessment, namely, for use in genomic analysis; downloadable software for genetic and bioinformatics analysis; downloadable software for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software, namely, data analysis software for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics; downloadable software for bioinformatics analysis of information derived through next generation sequencing (NGS); downloadable software for discovering and tracking indicators of disease through analysis of sequencing data; downloadable software for detecting the presence and prevalence of cancer molecules through analysis of sequencing data; universal serial bus (USB) flash drives, memory cards, and solid state drives with software installed thereon, namely, software for genetic and bioinformatics analysis; electronic devices, namely, tablet computers, desktop computers, and mobile workstations, with software installed thereon, namely, software for genetic and bioinformatics |
| Goods and Services | Reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being used for medical and veterinary purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical and veterinary purposes; biological and biochemical kits for medical and veterinary diagnostic purposes; reagents, assays, enzymes, nucleotides, buffers, and chemical and biological preparations for diagnostic purposes; reagents and reagent kits for amplifying, analyzing, labeling, and detecting nucleic acids for medical and veterinary purposes; reagents and reagent kits for monitoring the efficacy of therapies through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits for determining the presence of diseases through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits for monitoring therapeutic response and the recurrence of diseases through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits detecting cancer molecules in bodily fluids for medical and veterinary purposes; diagnostic substances for medical and veterinary use |
| Goods and Services | Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of sequencing data to detect the presence and prevalence of cancer molecules; management services, namely, management of business information insights learned through analysis of the information relating to preventative medicine marketability |
| Goods and Services | Reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and diagnostic research; biological and biochemical reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for selectively amplifying nucleic acid fragments for scientific research, clinical research, and diagnostic research; biological and biochemical kits for scientific research, clinical research, and diagnostic research; reagents, assays, enzymes, nucleotides, buffers, and chemical and biological preparations for diagnostic purposes; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with amplifying, analyzing, labeling, and detecting nucleic acids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with monitoring the efficacy of therapies through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with determining the presence of diseases through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with monitoring therapeutic response and the recurrence of diseases through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with detecting cancer molecules in bodily fluids |
| Goods and Services | Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of diagnostics; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical purposes, health and wellness assessment services; providing health and wellness information; medical services, namely, diagnostic testing for the presence of cancer molecules in bodily fluids; diagnostic testing relating to human health; medical testing services relating to the diagnosis, treatment, and recurrence monitoring of disease; management services, namely, management of medical information derived through nucleic acid sequencing, including next-generation sequencing (NGS), and information gathered through analysis of the medical information |
| Goods and Services | Software as a service (SaaS), namely, hosting non-downloadable software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids, , genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; data processing services for medical, clinical, and scientific purposes; developing diagnostic testing models for others for medical, clinical, and scientific purposes; genetic testing for scientific research purposes; scientific consulting relating to scientific research; scientific services, namely, detection and analysis of cancer molecules in bodily fluids; scientific, clinical, and diagnostic research in the field of bioinformatics; scientific, clinical, and diagnostic research in the fields of disease detection and management; scientific, clinical, and diagnostic research in the fields of cancer discovery, cancer management, therapy efficacy, and recurrence monitoring |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 24, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pillar Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Natick, MA 01760 |
| Party Name | Pillar Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Natick, MA 01760 |
| Event Date | Event Description |
| Friday, January 21, 2022 | NEW APPLICATION ENTERED |
| Monday, January 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 26, 2022 | ASSIGNED TO EXAMINER |
| Monday, November 7, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, November 7, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, November 7, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 9, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 9, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 24, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 13, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 8, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 1, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 1, 2024 | SOU EXTENSION 1 FILED |
| Thursday, February 1, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, February 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 13, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 30, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 30, 2024 | SOU EXTENSION 2 FILED |
| Monday, January 13, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 13, 2025 | SOU EXTENSION 3 FILED |
| Monday, January 13, 2025 | SOU EXTENSION 3 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |